New Drug Combo Slashes Bad Cholesterol by Nearly 50%A study shows that the combination of Obicetrapib and Ezetimibe can significantly reduce LDL cholesterol in patients unresponsive to statins.
AstraZeneca Bets Big on Cell Therapy with $1B ISOBiotech AcquisitionAstraZeneca will acquire ISOBiotech for $1 billion, enhancing its cell therapy capabilities and reducing treatment times significantly.
Is Your Child Struggling with Depression? Recognize the Signs EarlyChildhood depression is rising, with significant increases in cases. Parents should recognize signs and seek professional help for their children.
What Happens When Your Mind Splits? Exploring Dissociative Identity Disorder (DID)Dissociative Identity Disorder (DID) involves fragmented identities and a disconnection from self, requiring therapy for effective treatment.
Can’t Sleep? Here Are Two Proven Techniques to Help You Finally RestTo improve insomnia, use stimulus control (limit bedroom use to sleep) and relaxation techniques such as breathing to ease tension.
When Eye Contact Is Your Enemy: 10 Scary Reality of ScopophobiaSuppose you find it challenging to maintain eye contact to the point of being diagnosed with scopophobia? Here are details about it.
China's Immune Therapy Stocks Soar as Research Delivers Promising ResultsBaidu AIChinese immunotherapy stocks are leading the rebound in the Chinese stock market with a 10-d ...
Must-Reads
1
Shaw Prize winner Baumeister on breakthroughs that changed cell imaging
LATEST
2
Coach-athlete interaction at marathon finish sparks online debate
LATEST
3
Seoul shares snap 2-day drop on hopes for rate cut, eased AI fear; won rebounds
LATEST
4
Hanwha revamps US investment arm for defense push
LATEST
5
S. Korea asks Lone Star to reimburse legal costs after winning annulment in investor dispute
New Drug Combo Slashes Bad Cholesterol by Nearly 50% A study shows that the combination of Obicetrapib and Ezetimibe can significantly reduce LDL cholesterol in patients unresponsive to statins.
AstraZeneca Bets Big on Cell Therapy with $1B ISOBiotech Acquisition AstraZeneca will acquire ISOBiotech for $1 billion, enhancing its cell therapy capabilities and reducing treatment times significantly.
Is Your Child Struggling with Depression? Recognize the Signs Early Childhood depression is rising, with significant increases in cases. Parents should recognize signs and seek professional help for their children.
What Happens When Your Mind Splits? Exploring Dissociative Identity Disorder (DID) Dissociative Identity Disorder (DID) involves fragmented identities and a disconnection from self, requiring therapy for effective treatment.
Can’t Sleep? Here Are Two Proven Techniques to Help You Finally Rest To improve insomnia, use stimulus control (limit bedroom use to sleep) and relaxation techniques such as breathing to ease tension.
When Eye Contact Is Your Enemy: 10 Scary Reality of Scopophobia Suppose you find it challenging to maintain eye contact to the point of being diagnosed with scopophobia? Here are details about it.
China's Immune Therapy Stocks Soar as Research Delivers Promising Results Baidu AIChinese immunotherapy stocks are leading the rebound in the Chinese stock market with a 10-d ...
Hot Topics